| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $63.5M | +60.3% |
| SG&A Expense | $39.1M | +74.3% |
| Operating Income | -$102.6M | -65.3% |
| Pre-tax Income | -$90.0M | -50.0% |
| Income Tax | $239K | -33.2% |
| Net Income | -$90.2M | -49.5% |
| EPS (Basic) | -$1.27 | +24.0% |
| EPS (Diluted) | -$1.27 | +24.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.9M | -44.2% |
| Short-term Investments | $183.5M | +31.2% |
| Current Assets | $267.4M | -6.2% |
| Total Assets | $268.5M | -6.4% |
| Current Liabilities | $11.9M | +41.0% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $13.2M | +30.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$67.4M | -37.2% |
| Capital Expenditures | $52K | -81.1% |
| Investing Cash Flow | -$38.0M | -70.6% |
| Financing Cash Flow | $42.0M | -74.9% |
| Free Cash Flow | -$67.4M | -36.6% |
| Stockholders' Equity |
| $255.4M |
| -7.8% |